Wallentin L - Search Results

1

Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-a case-control study.

Varenhorst C, Koul S, Erlinge D, Lagerqvist B, Siegbahn A, Wallentin L, James S. Varenhorst C, et al. Among authors: wallentin l. Am Heart J. 2011 Aug;162(2):363-71. doi: 10.1016/j.ahj.2011.06.003. Epub 2011 Jul 20. Am Heart J. 2011. PMID: 21835299 Clinical Trial.

2

Persistence of the prothrombotic state after acute coronary syndromes: implications for treatment.

Bahit MC, Granger CB, Wallentin L. Bahit MC, et al. Among authors: wallentin l. Am Heart J. 2002 Feb;143(2):205-16. doi: 10.1067/mhj.2002.120767. Am Heart J. 2002. PMID: 11835022 Review.

3

Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study.

Wallentin L, Bergstrand L, Dellborg M, Fellenius C, Granger CB, Lindahl B, Lins LE, Nilsson T, Pehrsson K, Siegbahn A, Swahn E. Wallentin L, et al. Eur Heart J. 2003 May;24(10):897-908. doi: 10.1016/s0195-668x(03)00006-x. Eur Heart J. 2003. PMID: 12714021 Clinical Trial.

4

Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy.

Venge P, Johnston N, Lagerqvist B, Wallentin L, Lindahl B; FRISC-II Study Group. Venge P, et al. Among authors: wallentin l. Clin Chem. 2003 Jun;49(6 Pt 1):880-6. doi: 10.1373/49.6.880. Clin Chem. 2003. PMID: 12765983 Clinical Trial.

5

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.

James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, Barnathan ES, Califf R, Topol EJ, Simoons ML, Wallentin L. James SK, et al. Among authors: wallentin l. Circulation. 2003 Jul 22;108(3):275-81. doi: 10.1161/01.CIR.0000079170.10579.DC. Epub 2003 Jul 7. Circulation. 2003. PMID: 12847065 Clinical Trial.

6

Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial.

James S, Armstrong P, Califf R, Simoons ML, Venge P, Wallentin L, Lindahl B. James S, et al. Among authors: wallentin l. Am J Med. 2003 Aug 15;115(3):178-84. doi: 10.1016/s0002-9343(03)00348-6. Am J Med. 2003. PMID: 12935823 Clinical Trial.

7

Effects of an early invasive strategy on ischemia and exercise tolerance among patients with unstable coronary artery disease.

Diderholm E, Andrén B, Frostfeldt G, Genberg M, Jernberg T, Lagerqvist B, Lindahl B, Wallentin L. Diderholm E, et al. Among authors: wallentin l. Am J Med. 2003 Dec 1;115(8):606-12. doi: 10.1016/j.amjmed.2003.06.003. Am J Med. 2003. PMID: 14656612 Clinical Trial.

8

N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.

Jernberg T, Lindahl B, Siegbahn A, Andren B, Frostfeldt G, Lagerqvist B, Stridsberg M, Venge P, Wallentin L. Jernberg T, et al. Among authors: wallentin l. J Am Coll Cardiol. 2003 Dec 3;42(11):1909-16. doi: 10.1016/j.jacc.2003.07.015. J Am Coll Cardiol. 2003. PMID: 14662251 Free article.

9

Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction.

Björklund E, Lindahl B, Johanson P, Jernberg T, Svensson AM, Venge P, Wallentin L, Dellborg M; ASSENT-2 and ASSENT-PLUS Study Groups. Björklund E, et al. Among authors: wallentin l. Eur Heart J. 2004 Jan;25(2):113-20. doi: 10.1016/j.ehj.2003.10.025. Eur Heart J. 2004. PMID: 14720527 Clinical Trial.

10

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy.

James SK, Siegbahn A, Armstrong P, Barnathan E, Califf R, Simoons ML, Wallentin L. James SK, et al. Among authors: wallentin l. Am Heart J. 2004 Feb;147(2):267-74. doi: 10.1016/j.ahj.2003.09.014. Am Heart J. 2004. PMID: 14760324 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

845 results

Search Page

Filters